Pregled po projektu: 134007
Pronađeno 27 radova
-
1.Tarle, Marko; Trnski, Davor; Ružić, Boris; Spajić, Boro; Reljić, Ante; Anzulović, Zdravko; Katušić, Josip; Kraus, Ognjen; Ahel, Zaky; Kraljić, Ivo.Neuroendocrine differentiation in subclinically detected prostate cancer and during a subsequent disease progression. // Anticancer Research / Delinassios, John (ur.).
Atena: International Institute for Anticancer Research, 2001. str. 1660-1661 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
2.Tarle, Marko; Ahel, Zaky; Kovačić, Ksenija.Neuroendocrine differentiation and androgen deficient environment in prostate cancer patients. // Anticancer Research / Delinassios, John (ur.).
Atena: International Institute for Anticancer Research, 2001. str. 1660-1660 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
3.Tarle, Marko.Neuroendocrine structures in prostate cancer patients. // Anticancer Research / Delinassios, John (ur.).
Atena: International Institute for Anticancer Research, 2001. str. 1659-1660 (plenarno, međunarodna recenzija, sažetak, znanstveni) -
4.Ahel, Zaky; Kovačić, Ksenija; Kraljić, Ivo; Trnski, Davor; Tarle, Marko.Estramustine therapy in Chromogranin A-positive Prostate Cancer Patients. // Proceedings, 11th International Prostate Cancer Update / Crawford, E David (ur.).
Denver (CO): Medical Education Collaborative, 2001. str. 331-331 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
5.Ahel, Zaky; Kraljić, Ivo; Kovačić, Ksenija; Tarle, Marko.Impact of neuroendocrine differentiation on on false positive %FPSA findings and bone metastases in newly diagnosed prostate cancer patients. // Proceedings, 11th International Prostate Cancer Update / Crawford, David (ur.).
Denver (CO): Medical Education Collaborative, 2001. str. 278-278 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
6.Ahel, Zaky; Kovačić, Ksenija; Tarle, Marko.Cross-correlation of serum Chromogranin A, %F-PSA and bone scans in prostate cancer diagnosis. // Anticancer Research, 21(2B) (2001), 1363-1366 (međunarodna recenzija, članak, znanstveni)
-
7.Ahel, Zaky; Kovačić, Ksenija; Kraljić, Ivo; Tarle, Marko.Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients. // Anticancer Research, 21 (2001), 1475-1480 (međunarodna recenzija, članak, znanstveni)
-
8.Tarle, MarkoSerum chromogranin A level vs. false negative F/TPSA data in prostate cancer diagnosis // European Urology, 38 (2000), 4; 505-505 (međunarodna recenzija, članak, znanstveni)
-
9.Tarle, MarkoSerum Chromogranin A in metastatic prostate cancer patients // Anticancer Research, 16 (1999), 6; 5663-5666 (međunarodna recenzija, članak, znanstveni)
-
10.Kovačić, Ksenija; Tarle, Marko; Kusić, Zvonko.The role of bone scanning in the diagnosis and monitoring of patients with prostatic cancer // Acta clinica Croatica, 37 (1998), 3; 265-267 (podatak o recenziji nije dostupan, pregledni)
-
11.Tarle, Marko; Reljić, Ante; Spajić, Boris; Ružić, Boris; Trnski, Davor; Kraus, Ognjen; Kraljić, Ivo.Is Finasteride therapy of BPH a route to the early detection of prostzate cancer in situ? // Drugi hrvatski urološki kongres / Peterković, Vjerislav. (ur.).
Rijeka: Hrvatsko urološko društvo, 1998. str. 71-71 (predavanje, sažetak, znanstveni) -
12.Tarle, MarkoSupklinička dijagnostika i praćenje raka prostate. // Suvremeni pristupi u dijagnostici i liječenju raka prostate. / Šamija, Mirko. (ur.).
Zagreb: Klinika za tumore, Zagreb, 1998. str. 12-12 (pozvano predavanje, domaća recenzija, sažetak, pregledni) -
13.Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Trnski, Davor; Reljić, AnteSerum TPS and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy // From Tumor Biology to Clinical Oncology (Tumor Biology, Vol. 19, Suppl. 2, 1998)
Umeå, Švedska, 1998. str. 21-21 (poster, sažetak, znanstveni) -
14.Tarle, Marko; Kraus, Ognjen; Kraljić, Ivo; Trnski, Davor; Anzulović, Zdravko; Katušić, Josip; Reljić, Ante; Ružić, BorisSubclinical distinction of symptomatic BPH from prostate cancer in Finasteride treated patients. // Journal of Tumor Marker Oncology. 13(2), 1998 Sum.
Lugano, Švicarska, 1998. str. 32-33 (poster, sažetak, znanstveni) -
15.Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Tarle, Robert; Kaštelan, MajaT-PSA, NK activity and TPS value during prostate cancer progression and in responders to therapy. // Journal of tumor marker oncology, 13 (1998), 2; 33-33 (međunarodna recenzija, članak, znanstveni)
-
16.Tarle, Marko; Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Kovačić, KsenijaPercent free PSA (%F-PSA) value in follow-up treatment of hormone sensitive prostate cancer. %F-PSA as a succeful prognosticator to hormone therapy. // Anticancer research, 18 (1998), 6c. (međunarodna recenzija, članak, znanstveni)
-
17.Tarle, Marko; Kraljić, Ivo; Ružić, Boris; Anzulović, Zdravko; Trnski, Davor; Katušić, Josip; Reljić, Ante; Kovačić, Ksenija.Conversion of hormone sensitive prostate cancer to hormone resistant disease: A subclinical detection. // Anticancer research, 18 (1998), 6c; 4958-4959 (međunarodna recenzija, članak, znanstveni)
-
18.Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Trnski, Davor; Reljić, AnteSerum TPS value and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy and a probe used in staging protocols. // Anticancer research, 18 (1998), 6c; 4957-4957 (međunarodna recenzija, članak, znanstveni)
-
19.Tarle, Marko; Reljić, Ante; Kraus, Ognjen; Kraljić, Ivo; Ruži, Boris; Trnski, DavorA novel procedure for the detection of prostate cancer in situ by applying Finasteride therapy. // Anticancer research, 18 (1998), 6c; 4959-4959 (međunarodna recenzija, članak, znanstveni)
-
20.Tarle, MarkoAnalysis of TPS application in prostate cancer : a critical commentary // Journal of tumor marker oncology, 12 (1997), 2; 74-74 (međunarodna recenzija, članak, znanstveni)
-
21.Kraljić, Ivo; Katušić, Josip; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Ružić, Boris; Tarle, MarkoThe use of free and total serum PSA values (F/T%PSA) in discriminating BPH from latent, manifest and "manifest-to-be" prostatic carcinoma // Journal of tumor marker oncology, 12 (1997), 4; 57-58 (podatak o recenziji nije dostupan, znanstveni)
-
22.Tarle, Marko; Kraljić, IvoF/T%PSA values in patients with prostatic disorders and T-PSA ranging 3-15 ng/ml : introduction into the use in screening protocols // Tumor Biology, Suppl 2 (From Basic Cancer Research to Clinical Application)
Montreux, Švicarska, 1997. str. 29-29 (poster, sažetak, znanstveni) -
23.Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Tarle, MarkoIntroduction into the use of serum F/T%PSA value in distinguishing between BPH, latent and manifest prostatic adenocarcinoma // British journal of urology, 80 (1997), suppl. 2; 246-246 (međunarodna recenzija, članak, znanstveni)
-
24.Ružić, Boris; Reljić, Ante; Trnski, Davor; Kraus, Ognjen; Anzulović, Zdravko; Katušić, Josip; Tarle, MarkoMultivariate analysis of serum tumor markers in prostate cancer patients treated with triptorelin and maximal androgen blockade // Acta clinica Croatica, 36 (1997), 1; 41-48 (podatak o recenziji nije dostupan, članak, stručni)
-
25.Tarle, Marko; Kraljić, IvoSerum free/total percent PSA value as a clinical tool for discriminating latent from manifest prostatic carcinoma // Acta clinica Croatica, 36 (1997), 1; 15-20 (međunarodna recenzija, članak, znanstveni)
